Predicting chemotherapy response in advanced breast cancer
Part of Cancer, Skin clinical trials.
This trial studies whether doctors can predict how well chemotherapy will work for women with locally advanced breast cancer before surgery. It may help match patients to more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have been diagnosed with breast cancer through a biopsy.
- Your cancer must be locally advanced, meaning it has spread to nearby tissue but not to distant organs.
- You cannot have cancer that has spread to other parts of the body.
- You cannot have another type of cancer now.
- You must be healthy enough to receive chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different treatment plans for women with newly diagnosed, locally advanced breast cancer (stage IIIb-IIIc). It aims to find the most effective combination of surgery, chemotherapy, and radiotherapy. If you are a woman aged 18-70 with this diagnosis and your tumor can be surgically removed, this trial may be an option for you.
This study looks at how well a computer model can predict if breast cancer will completely respond to chemotherapy before surgery. It is for people with early-stage breast cancer who are about to start neoadjuvant chemotherapy.
This trial looks at tiny particles called exosomes from your blood and leftover tumor tissue to see if they can predict how well chemotherapy works before surgery. The goal is to find markers that help doctors choose the best treatment for you.
This trial tests whether we can predict how well hormone therapy works before surgery for early-stage breast cancer. It may help women with estrogen receptor-positive, HER2-negative or HER2-low breast cancer avoid or tailor treatments.
This trial tests a personalized approach to treating breast cancer that has spread to nearby lymph nodes. Your surgery and radiation will be tailored to how well your cancer responds to initial chemotherapy or hormone therapy.
This study grows mini versions of your breast cancer tumor in the lab to understand why some cancers resist chemotherapy. Researchers use this information to help predict which treatment might work best for you.
Hear when a new Locally Advanced Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.